---
title: "The cellular immunotherapy sector has seen a short-term surge, with Staidson BioPharm rising over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242300903.md"
description: "The cell immunotherapy sector saw a short-term surge, with Staidson BioPharm rising over 10%, followed by XUERONG, RemeGen, Kingmed Diagnostics, Lummy, and Heyuan Bio"
datetime: "2025-05-29T01:37:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242300903.md)
  - [en](https://longbridge.com/en/news/242300903.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242300903.md)
---

# The cellular immunotherapy sector has seen a short-term surge, with Staidson BioPharm rising over 10%

The cell immunotherapy sector saw a short-term surge, with Staidson BioPharm rising over 10%, followed by XUERONG, RemeGen, Kingmed Diagnostics, Lummy, and Heyuan Bio

### Related Stocks

- [300006.CN](https://longbridge.com/en/quote/300006.CN.md)
- [300511.CN](https://longbridge.com/en/quote/300511.CN.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [603882.CN](https://longbridge.com/en/quote/603882.CN.md)
- [300204.CN](https://longbridge.com/en/quote/300204.CN.md)
- [688238.CN](https://longbridge.com/en/quote/688238.CN.md)

## Related News & Research

- [11:23 ETTOUS les JOURS BRINGS OFFICIAL BTS THE CITY ARIRANG POP-UP EXPERIENCE TO LAS VEGAS BAKERY CAFÉS](https://longbridge.com/en/news/286793282.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Forget cellular data: China’s telecoms giants are selling AI token plans](https://longbridge.com/en/news/286750580.md)